LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. is a registered legal entity registered in United States under 4586945, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 21 April 2020 and lists its registered address as United States. 3 shareholders are on record for LENZ Therapeutics, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 5 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
3
Three shareholders are currently on record for LENZ Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is UBS Group AG, holding 6.8% — the largest recorded stake — followed by Vanguard Group Inc at 5.7%; the remaining 1 shareholder shown holds smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| UBS Group AG | 6.8% | California Secretary of State — bizfile Online | |
| Vanguard Group Inc | 5.7% | California Secretary of State — bizfile Online | |
| T. Rowe Price Health Sciences Fund, Inc. | 0.8% | California Secretary of State — bizfile Online |
Officers
5
The President, Ceo, Secretary & Director of LENZ Therapeutics, Inc. currently on record is Evert B. Schimmelpennink; five officers are currently on record for LENZ Therapeutics, Inc., filed with California Secretary of State — bizfile Online.
The register reports 18 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at LENZ Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
LENZ Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span United States, Netherlands jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
LENZ Therapeutics, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns LENZ Therapeutics, Inc.?
Three shareholders are currently on record for LENZ Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is UBS Group AG, holding 6.8% — the largest recorded stake — followed by Vanguard Group Inc at 5.7%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is LENZ Therapeutics, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for LENZ Therapeutics, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does LENZ Therapeutics, Inc. have on record?
3 shareholders are shown on record for LENZ Therapeutics, Inc..
What is LENZ Therapeutics, Inc.'s company registration number?
LENZ Therapeutics, Inc.'s registration number is 4586945, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is LENZ Therapeutics, Inc. still an active company?
LENZ Therapeutics, Inc.'s status on California Secretary of State — bizfile Online is listed as active.
When was LENZ Therapeutics, Inc. incorporated?
LENZ Therapeutics, Inc. was incorporated on 21 April 2020, according to California Secretary of State — bizfile Online.
What is LENZ Therapeutics, Inc.'s registered address?
The registered address on file for LENZ Therapeutics, Inc. is United States.
Who are the officers/directors of LENZ Therapeutics, Inc.?
The President, Ceo, Secretary & Director of LENZ Therapeutics, Inc. currently on record is Evert B. Schimmelpennink; five officers are currently on record for LENZ Therapeutics, Inc., filed with California Secretary of State — bizfile Online. Management authority at LENZ Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does LENZ Therapeutics, Inc. have a parent company or subsidiaries?
LENZ Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Those 2 subsidiaries span United States, Netherlands jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to LENZ Therapeutics, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to LENZ Therapeutics, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access LENZ Therapeutics, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like LENZ Therapeutics, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 5 October 2026.